Skip to main content

Advertisement

Table 3 Acceptability between the five kinds of antipsychotic groups after 6–8 weeks of treatment (N, %)

From: The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial

Groups N Disc. of initially assigned APs Use of concomitant APs Maintaining initially assigned APs
Aripiprazole 39 16 (0.41) 8 (0.21) 15 (0.38)
Risperidone 43 20 (0.47) 3 (0.069) 20 (0.47)
Quetiapine 39 12 (0.31) 4 (0.10) 23 (0.59)a
Olanzapine 35 14 (0.4) 0 21 (0.60)a
Ziprasidone 19 12 (0.63) 2 (0.11) 5 (0.26)
  1. Values are represented as N: number of patients; APs: antipsychotics; Disc.: discontinuation
  2. aComparison of quetiapine and olanzapine with ziprasidone, both with P < 0.05